# FDA Inspection 1220748 - Triumpharma Bioanalytical Lab - August 10, 2023

Source: https://www.keypedia.com/records/fda_inspections/triumpharma-bioanalytical-lab/72f1c801-2f1a-4c63-848d-e3bfa9a56427
Source feed: FDA_Inspections

> FDA Inspection 1220748 for Triumpharma Bioanalytical Lab on August 10, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1220748
- Company Name: Triumpharma Bioanalytical Lab
- Inspection Date: 2023-08-10
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1117529 - 2019-12-12](https://www.keypedia.com/records/fda_inspections/triumpharma-bioanalytical-lab/69c961bf-d118-4169-be3e-ee956551aee6)
- [FDA Inspection 1110557 - 2019-10-31](https://www.keypedia.com/records/fda_inspections/triumpharma-bioanalytical-lab/940e5a07-6f17-4f01-a68c-792598f66bf7)

Company: https://www.keypedia.com/companies/triumpharma-bioanalytical-lab/fab1d081-229c-4fad-a5ae-3c4be83e149e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c